CeQur

CeQur is a medical technology company, which has developed an insulin infuser for the care of type 2 Diabetes mellitus patients.

The CeQur device is a small discreet and wearable insulin patch infuser. It will be one of the smallest and easiest continuous delivery options as it will administer the basal and bolus rates of insulin over three days. The CeQur insulin infuser includes a disposable insulin reservoir that is connected to a reusable electronic messenger. The device easily attaches to the patient's abdominal area with a safe and secure adhesive backing. The product is currently in clinical trials in Europe. It will compete with delivery pens and syringes on the market, but with the proposed benefit of avoiding daily self-injections, which should increase patients’ compliance and clinical outcome.


Recent News

April 13, 2010
CeQur SA names Robert O'Holla EVP for Regulatory Affairs

 
October 7, 2009
CeQur SA Appoints Eric Milledge Chairman of the Board of Directors

 
January 5, 2009
CeQur SA Completes Series A Investment with 10 Million Dollar Raise in December 2009

 


Company Info
 
Country: Switzerland
Industry:    LS
Sector: medical technology
Status: Unrealized
Vehicle: Endeavour II LP


Key persons
 Eric Milledge, Chairman; James Peterson, CEO


Company website
 www.cequrcorp.com


Endeavour Vision Team
 
Damien Tappy
Daniel Bertholet
© Endeavour Vision SA 2006-2012 Terms & Conditions